ChartMill assigns a Buy % Consensus number of 60% to LMNX. The Buy consensus is the weighted average rating of the current analysts ratings.
DEF DAILY TARG 2X L LMND ETF / LMNX FAQ
What does LMNX do?
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company is headquartered in Austin, Texas and currently employs 1,325 full-time employees. The company went IPO on 2000-03-30. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The firm has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The firm primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
What is the current price of LMNX stock?
The current stock price of LMNX is 28.2844 USD. The price decreased by -2.17% in the last trading session.
What is the ChartMill rating of DEF DAILY TARG 2X L LMND ETF stock?
LMNX has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 0 out of 10.